News About: Pharm. Industry
Green Cross remarkably grew up in first half of 2005.
Green Cross reported 155,651 MW of sales during the first half of this year, 15.2 BW of operating income, 26,670 MW of ordinary income and 18.7 BW of net income, largely led by the sales of blood preparations at 70,35...
Boryung to register 2 process patents for Tamsulosin and other.
Boryung announced on Aug. 10 that two patents were registered in Korea including a purification process for Tamsulosin, a drug for prostate enlargement, characterized in which a tamsulosin carboxylate salt with 99.0% ...
Pfizer Korea to strengthen strategic alliance with local firms.
Pfizer Korea has reinforced their strategic business alliance with leading local pharmaceutical firms including Green Cross and Il Yang recently and other 7 companies for 22 products.
Green Cross distributes Pf...
Hanmi, 14% sales increase in first half of 2005
The sales of Hanmi during the first half of FY2005 rose by about 14% mainly owing to favorable market development of Amodipine (amlodipine).
Hanmi reported 19.6 BW of operating income, 24% up from the previous yea...
Daewoong's Q1 sales grew up with Gasmotin and Nicostop.
Daewoong reported 80,238 million won of sales during the Q1 of 2005 (April to June 2005), which was nearly 10 billion won of increase over the same period of last year, 9,784 MW of operating income, 8,784 MW of ordina...
CJ to export rhG-CSF to UK GeneMedix.
CJ pharmaceutical division announced on Aug. 9 for Leucocain (rhG-CSF), a recombinant granulocyte colonial stimulating factor, to export to GeneMedix in England.
An insider of CJ Pharm. division said that the expor...
Kuhnil to acquire exclusive license for a super antibiotic.
Kuhnil made an exclusive distribution agreement for Cubicin, a super antibiotic, even sensitive to MRSA (methicillin-resistant Staphylococcus aureus), with Cubist Inc., located in Boston, U.S.A on July 14.
Cubist I...
Daewoong to decide wholesale policies after 3 month test.
Daewoong indicated that their new wholesale policies controversial by the wholesaler's group seem to be finalized after the 3 months market test, according to the Seoul Pharmaceutical Association (SPA).
When the SP...
Drug industries to solidify their identities via brand changes.
The pharmaceutical industry showed an active movement of changing their company names for the purpose of establishing their identities and leap-up targeting the new bio drugs and its science for their business growing...
Dongwha to register patent for a Quinolone derivative.
Dongwha announced on Aug. 9 that the company completed a patent registration under the No. 0497942 for an optically active form of 7-pyrrolidine quinolin carboxylic acid derivative and its production process in Korea....
